This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Gemvax as. Active years: 2007-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2013
Title: The Innovative Contributions of Mona Moller
Introduction
Mona Moller is a notable inventor based in Porsgrunn, Norway. She has made significant contributions to the field of cancer research through her innovative work on isolated peptides. With a total of 2 patents, her inventions focus on developing cancer vaccines and therapeutically effective compositions.
Latest Patents
Mona Moller's latest patents involve isolated peptides that are fragments of protein products arising from frameshift mutations in genes associated with cancer. These isolated peptides are capable of eliciting T cell immunity against cells harboring genes with such frameshift mutations. The patents describe cancer vaccines and therapeutically effective compositions containing these peptides, showcasing her commitment to advancing cancer treatment.
Career Highlights
Mona Moller is associated with Gemvax AS, where she continues to work on her innovative projects. Her research has the potential to significantly impact cancer therapies and improve patient outcomes.
Collaborations
Mona collaborates with esteemed colleagues such as Gustav Gaudernack and Jon Amund Eriksen, further enhancing the scope and impact of her research.
Conclusion
Mona Moller's contributions to cancer research through her innovative patents highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile